Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics

save search

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Published: 2024-04-03 (Crawled : 05:00) - globenewswire.com
ADXN | $25.74 0.66% 0.66% 18K

Health Technology

| 93.13% | O: 14.12% H: 15.82% C: 1.95%
million disorders neurological therapeutics

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 21:00) - globenewswire.com
JSPR | $26.19 -5.52% -5.84% 110K

| 5.8% | O: 5.76% H: 4.44% C: -2.2%
conference therapeutics

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M

Health Technology

| -7.59% | O: 0.63% H: 0.0% C: -6.29%
nasdaq grants therapeutics

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
FATE | $5.645 -5.13% -5.5% 2.7M

Health Technology

| -15.15% | O: -0.29% H: 7.52% C: 3.39%
award nasdaq therapeutics employee

Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
COEP | $0.3801 -9.2% -10.13% 400K

| 37.2% | O: 8.16% H: 8.0% C: -4.64%
award research therapeutics

Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M

Health Technology

| -5.81% | O: -1.14% H: 0.02% C: -1.06%
therapeutics

Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
ADTX | $2.72 -9.64% -10.66% 82K

Health Technology

| -7.67% | O: 57.3% H: 6.28% C: -34.28%
therapeutics acquired agreement

Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
CGTX | $1.89 -3.57% -3.7% 62K

| 7.1% | O: 4.37% H: 0.0% C: -5.24%
conference therapeutics

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
VERA | $46.695 -2.66% -2.73% 1.1M

Professional, Scientific, and T...

| 12.8% | O: -3.66% H: 0.0% C: 0.0%
congress association renal therapeutics

Pliant Therapeutics to Participate in Upcoming Investor Events
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
PLRX | $13.55 -4.24% -4.43% 270K

Health Technology

| -3.08% | O: -0.62% H: 1.17% C: 1.17%
therapeutics

Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
Published: 2024-04-02 (Crawled : 12:00) - prnewswire.com
INTS | $4.1 -10.68% -11.95% 43K

| -8.93% | O: -2.78% H: 0.45% C: -6.12%
conference therapeutics

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BCYC | $21.82 -2.15% -2.2% 170K

Health Technology

| -9.72% | O: -2.71% H: 0.65% C: -1.25%
conference bicycle therapeutics

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
AVTX | $14.97 0.47% 0.47% 91K

Manufacturing

| -23.31% | O: -22.8% H: 15.52% C: 1.07%
ICLR | $299.21 -2.22% -2.27% 380K

Health Technology

| -9.28% | O: -2.95% H: 0.0% C: -1.43%
BIIB | $196.76 -0.72% -0.72% 1.2M

Health Technology

| -8.03% | O: -1.11% H: 0.16% C: -2.56%
biotech leaders therapeutics

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
CARA S | $0.723 -5.38% -5.68% 440K

Health Technology

| -15.57% | O: 0.03% H: 2.62% C: 1.57%
conference therapeutics

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
TCRX | $7.66 -1.16% -1.17% 120K

Professional, Scientific, and T...

| -4.26% | O: -1.3% H: 0.0% C: -9.89%
conference presentation therapeutics

Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
NRIX | $15.46 -7.65% -8.28% 2.5M

Health Technology

| 15.93% | O: -1.59% H: 6.37% C: 4.57%
sciences collaboration extension therapeutics

Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
AUTL | $4.9 -2.39% -2.45% 790K

Health Technology

| -18.11% | O: -7.83% H: 3.27% C: -2.48%
authorization application leukemia therapeutics

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 21:00) - globenewswire.com
GTHX | $4.31 -5.28% -5.57% 670K

Health Technology

| 0.0% | O: -1.32% H: 4.01% C: 2.45%
nasdaq grants therapeutics

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
ADCT | $4.37 -0.46% 0.0% 460K

Health Technology